Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
death
Biotech
BMS sheds light on patient death in CAR-T trial
BMS shared more details with Fierce about the death of a patient who received the pharma's investigational CAR-T in a multiple sclerosis trial.
Marissa Russo
Oct 26, 2026 7:00am
Veru wraps up COVID trial early and heads to regulators
Apr 11, 2022 10:30am
FDA stops Kura's early-phase leukemia trial after patient dies
Nov 24, 2021 9:55am
Alnylam halts fitusiran trials after patient with hemophilia dies
Sep 7, 2017 11:00am
Investors spooked by Kite CAR-T death, but biotech is confident
May 8, 2017 12:17pm
Hanmi hit over failure to disclose olmutinib cancer trial side effect
Apr 17, 2017 8:31am
